Using network pharmacology, Yang et al. (2020) found that the Huoxue Rongluo formula mainly promoted angiogenesis in cerebral infarctions by regulating oxidative stress, cell apoptosis, the proliferation of ECs and smooth muscle cells, and the hypoxia-inducible factor 1 (HIF-1) and mechanistic target of rapamycin (mTOR) signaling pathways. The gene discussed is MTOR; the disease is cerebral infarction.